Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassay
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (9) , 1293-1297
- https://doi.org/10.1016/0959-8049(93)90076-r
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- MINIREVIEW: Estrogen Receptor Variants in Clinical Breast CancerMolecular Endocrinology, 1991
- Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoformsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifenCancer, 1991
- Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.Journal of Clinical Oncology, 1990
- Variant Estrogen Receptor mRNA Species Detected in Human Breast Cancer Biopsy SamplesMolecular Endocrinology, 1989
- A Variant Estrogen Receptor Messenger Ribonucleic Acid is Associated with Reduced Levels of Estrogen Binding in Human Mammary TumorsMolecular Endocrinology, 1988
- Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patientsBritish Journal of Cancer, 1980
- Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancerCancer, 1977